HCL AppScan vs ImmuniWeb comparison

"It comes with all of the templates that we need. For example, we are a company that is regulated by PCI. In order to be PCI compliant, we have a lot of checks and procedures to which we have to comply."

"We use it as a security testing application."

"We leverage it as a quality check against code."

"AppScan's most valuable features include its ability to identify vulnerabilities accurately, provide detailed remediation steps, and the newly introduced AI-powered features that enhance its functionality further."

"We are now deploying less defects to production."

"The most valuable feature of HCL AppScan is scanning QR codes."

"The static scans are good, and the SaaS as well."

"The solution is cheap."

"The solution's most valuable feature is reporting."

"ImmuniWeb is stable."

"I like the fully automated continuous discovery run by ImmuniWeb in the background. We do not need to rerun the same tests or the same scanning against our resources. We need to supply our IP addresses, domain names, and significant resources with special domain names and URLs, and we need to do it only once. Then we always have an up-to-date picture. I also like the integration with our single sign-on system. We do not need to maintain a separate set of usernames or user accounts. We can plug this ImmuniWeb service into our authentication technology, enabling two-factor authentication. We have secure authentication right out of the box. The other important feature I like is the executive view. You can easily switch from a technical view to an executive view and have a helicopter view of the compliance status. We can see how much effort is required and our current status."

"ImmuniWeb boasts a robust vulnerability detection mechanism, formidable threat mitigation, and an efficient remediation process, incorporating automation techniques and ALM strategies. The solution is highly stable. The solution is scalable. Editing Key Points for Review "Review about ImmuniWeb" What is our primary use case? We use the solution when we face challenges and urgent attention is needed for complex cases from our clients. To address this, we collaborate with the middleware, internal, and client teams to analyze and sort through intricate logs concerning our business cybersecurity program. How has it helped my organization? The solution helped us with one of our clients in the New York area contacted us about a data breach. In response, we swiftly organized a case meeting involving our client, internal, and email customer support teams. Together, we conducted an incident response, facilitating offline assistance for proper planning and risk management processes. We delved into the details of the data breach, identified how it occurred, and collaborated to rectify the issue. The client expressed satisfaction with the resolution process. What is most valuable? ImmuniWeb boasts a robust vulnerability detection mechanism, formidable threat mitigation, and an efficient remediation process, incorporating automation techniques and ALM strategies. It also focuses on consumer satisfaction and operates in English-speaking markets, primarily required by the UAE, the United States, Canada, and Australia, among other developed countries. For how long have I used the solution? We have been using this product for the past one and half years. What do I think about the stability of the solution? The solution is highly stable. I rate it a perfect ten. What do I think about the scalability of the solution? The solution is scalable. I rate it a nine out of ten. How are customer service and support? Support is generally excellent"

"After the assessment, you clearly know which assets require penetration testing."

"The initial setup process is user-friendly."

"The most valuable features are the SLA of Zero false-positives, less time of service development, validation of unlimited patched vulnerabilities, and several others."

"They should have a better UI for dashboards."

"The product has some technical limitations."

"They have to improve support."

"We would like to integrate with some of the other reporting tools that we're planning to use in the future."

"The tool should improve its output. Scanning is not a challenge anymore since there are many such tools available in the market. The product needs to focus on how its output is being used by end users. It should be also more user-friendly. One of the major challenges is in the tool's integration with applications that need to be scanned. Sometimes, the scanning is not proper."

"The solution needs to improve in some areas. The tool needs to add more languages. It also needs to improve its speed."

"There is one feature called SCA, which stands for Software Composition Analysis, that could be improved."

"The solution could improve by having a mobile version."

"ImmuniWeb sometimes shows previous scans instead of running tests."

"It would be better if they had an automated tagging feature. The tagging functionality currently requires manual tagging, and that's probably the most needed feature from my standpoint. We also do not have enough tools, enough features, or options to display different resources in the way we need. There are basic grouping and some filtering features, but we still cannot fully separate some flavors of our resources. However, we may not be aware of the latest features."

"A great idea would be to make a mobile application for the ImmuniWeb portal so that all information would be available on the go and from a mobile phone as well. It would be much more convenient."

"Its technical support could be better."

"A great idea would be to support using Discovery on the internal network, allowing delivery of all the features of the current Discovery to internal network resources."

"The deployment process on the cloud is straightforward, while on-premise can be complex. Support is generally excellent, although there can be delays in ticket resolution."

"The product’s interface for the web applications could be similar to Android and iOS versions."

"HCL AppScan is expensive."

"The price is very expensive."

"The product is moderately priced, though it's an investment due to extensive code analysis needs."

"The solution is moderately priced."

"AppScan is a little bit expensive. IBM needs to work a little bit on the pricing model, decreasing the license cost."

"The solution is cheap."

"The tool was expensive."

"Our clients are willing to pay the extra money. It is expensive."

"ImmuniWeb is relatively cheap. It's a competitive price compared to other products in the marketplace. It's worth the money we are paying for it."

"The platform is expensive if a large development is involved. However, it is less expensive for scheduled-based testing, quarterly or in a year."

"It is pretty expensive."

"It is pretty expensive."

"The values of ImmuniWeb are currently significantly below what is valued in the Chilean market for these services and solutions."

"I use the product's free version. The tool costs around 229 dollars."

"There should be the flexibility to change or add pricing, especially for pay-per-use cases."